VXLLF (Vaxil Bio) Cyclically Adjusted Book per Share: $0.29 (As of Mar. 2026)


VXLLF Vaxil Bio Ltd VXLLF
38 GF Score
Price $0.02
! 2 Warning Signs
View Full Analysis

What is Vaxil Bio Cyclically Adjusted Book per Share?

Vaxil Bio VXLLF -85.27% 38 Cyclically Adjusted Book per Share is $0.29 as of Mar. 2026. GuruFocus rates VXLLF with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Vaxil Bio's adjusted book value per share for the three months ended in Mar. 2026 was $0.230. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.29 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Vaxil Bio's average Cyclically Adjusted Book Growth Rate was -8.30% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -33.00% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -42.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Vaxil Bio was -33.00% per year. The lowest was -51.90% per year. And the median was -47.80% per year.

As of today (2026-06-29), Vaxil Bio's current stock price is $0.0221. Vaxil Bio's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was $0.29. Vaxil Bio's Cyclically Adjusted PB Ratio of today is 0.08.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vaxil Bio was 0.45. The lowest was 0.00. And the median was 0.00.


Vaxil Bio  (OTCPK:VXLLF) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vaxil Bio's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0221/0.29
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Vaxil Bio was 0.45. The lowest was 0.00. And the median was 0.00.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Vaxil Bio Cyclically Adjusted Book per Share Related Terms


Vaxil Bio Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Vaxil Bio's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vaxil Bio Cyclically Adjusted Book per Share Chart

Vaxil Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.02 1.68 0.63 0.38 0.29

Vaxil Bio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.32 0.03 0.13 0.29 0.29

VXLLF vs VRTX, REGN, ALNY: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Vaxil Bio's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vaxil Bio Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Vaxil Bio's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vaxil Bio's Cyclically Adjusted PB Ratio falls into.


VXLLF
38GF Score
Vaxil Bio Ltd VXLLF
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Vaxil Bio Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Vaxil Bio's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.23/132.2623*132.2623
=0.230

Current CPI (Mar. 2026) = 132.2623.

Vaxil Bio Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.234 102.002 1.600
201609 0.977 101.765 1.270
201612 0.515 101.449 0.671
201703 0.485 102.634 0.625
201706 0.215 103.029 0.276
201709 -1.245 103.345 -1.593
201712 -0.376 103.345 -0.481
201803 0.414 105.004 0.521
201806 0.365 105.557 0.457
201809 0.340 105.636 0.426
201812 0.182 105.399 0.228
201903 0.094 106.979 0.116
201906 0.026 107.690 0.032
201909 -0.050 107.611 -0.061
201912 -0.249 107.769 -0.306
202003 0.132 107.927 0.162
202006 0.148 108.401 0.181
202009 0.072 108.164 0.088
202012 0.264 108.559 0.322
202103 0.693 110.298 0.831
202106 0.652 111.720 0.772
202109 0.561 112.905 0.657
202112 0.485 113.774 0.564
202203 0.454 117.646 0.510
202206 0.409 120.806 0.448
202209 0.356 120.648 0.390
202212 0.305 120.964 0.333
202303 0.270 122.702 0.291
202306 0.244 124.203 0.260
202309 0.232 125.230 0.245
202312 0.242 125.072 0.256
202403 0.225 126.258 0.236
202406 0.209 127.522 0.217
202409 0.199 127.285 0.207
202412 0.184 127.364 0.191
202503 0.164 129.181 0.168
202506 0.185 129.892 0.188
202509 0.176 130.287 0.179
202512 0.248 130.366 0.252
202603 0.230 132.262 0.230

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.29 mean?
Vaxil Bio (VXLLF) has a Cyclically Adjusted Book per Share of $0.29 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vaxil Bio and its competitors.
Is Vaxil Bio's Cyclically Adjusted Book per Share too high?
Vaxil Bio's current Cyclically Adjusted Book per Share is $0.29. Overall, Vaxil Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Vaxil Bio's Cyclically Adjusted Book per Share compare to VRTX and REGN?
Vaxil Bio's Cyclically Adjusted Book per Share of $0.29 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Vaxil Bio and its competitors. Vaxil Bio's current Cyclically Adjusted Book per Share is $0.29. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaxil Bio stock overvalued right now?
Vaxil Bio (VXLLF) has a current Cyclically Adjusted Book per Share of $0.29. The current Cyclically Adjusted Book per Share is $0.29. Vaxil Bio's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Vaxil Bio (VXLLF), the current Cyclically Adjusted Book per Share is $0.29 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vaxil Bio Business Description

Other Exchanges VXL:Canada
Address 559 Briar Hill Avenue, Toronto, ON, CAN, M5N 1N1
Vaxil Bio Ltd is a biotechnology company focused on a novel drug discovery and development platform based on signal peptides for infectious diseases and cancer. In recent years, the Company has been more focused on P-EsbpDOX. The Company develops ImMucin, a MUC1 SP-derived vaccine that has completed a Phase 1/2 clinical trial for the treatment of multiple myeloma. It is also developing SP-based COVID-19 and tuberculosis vaccine/treatment candidates.
38GF Score

Get the complete analysis for VXLLF

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price